[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].

Advances in clinical pharmacology Pub Date : 1976-01-01
C Werning, H Vetter
{"title":"[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].","authors":"C Werning,&nbsp;H Vetter","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>1. In 20 of 20 patients (100%) with borderline hypertension Visken normalized the labile blood pressure. The high renin values after stimulation due to orthostasis and saluresis decreased significantly (p less than 0,01). 2. In 3 of 12 patients (25%) with hyporeninemic essential hypertension Visken alone normalized the blood pressure. The low renin values increased to the normal range. 3. In 4 of 18 patients (22%) with normoreninemic essential hypertension Visken normalized the blood pressure. The normal renin values showed a decreasing tendency within the normal range. 4. In 4 of 10 patients (40%) with hyperreninemic essential hypertension Visken normalized the high blood pressure. In 3 of these patients renin decreased distinctly. 5. In 4 of 20 patients (20%) with renal hypertension a therapy with Visken alone normalized the blood pressure. In 3 patients the high renin values decreased to the normal range. 6. In the most other patients of the groups II to V the additional therapy with diuretics and reserpine normalized the blood pressure. In these cases the renin values showed different reactions corresponding to the different effects of betablocking agents, saluretics or reserpine on the plasma renin activity [7]. 7. It is interesting, that Visken not only suppresses high renin values (borderline hypertension [6], hyperreninemic essential hypertension), but also increases low renin values to the normal range in patients with hyporeninemic essential hypertension. Because in essential hypertension the high blood pressure per se may be responsible for the renin suppression [3,4], this increase of renin activity is possibly the consequence of blood pressure reduction, while the decrease of renin activity after Visken may be the cause of blood pressure reduction.</p>","PeriodicalId":75437,"journal":{"name":"Advances in clinical pharmacology","volume":"11 ","pages":"54-60"},"PeriodicalIF":0.0000,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in clinical pharmacology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

1. In 20 of 20 patients (100%) with borderline hypertension Visken normalized the labile blood pressure. The high renin values after stimulation due to orthostasis and saluresis decreased significantly (p less than 0,01). 2. In 3 of 12 patients (25%) with hyporeninemic essential hypertension Visken alone normalized the blood pressure. The low renin values increased to the normal range. 3. In 4 of 18 patients (22%) with normoreninemic essential hypertension Visken normalized the blood pressure. The normal renin values showed a decreasing tendency within the normal range. 4. In 4 of 10 patients (40%) with hyperreninemic essential hypertension Visken normalized the high blood pressure. In 3 of these patients renin decreased distinctly. 5. In 4 of 20 patients (20%) with renal hypertension a therapy with Visken alone normalized the blood pressure. In 3 patients the high renin values decreased to the normal range. 6. In the most other patients of the groups II to V the additional therapy with diuretics and reserpine normalized the blood pressure. In these cases the renin values showed different reactions corresponding to the different effects of betablocking agents, saluretics or reserpine on the plasma renin activity [7]. 7. It is interesting, that Visken not only suppresses high renin values (borderline hypertension [6], hyperreninemic essential hypertension), but also increases low renin values to the normal range in patients with hyporeninemic essential hypertension. Because in essential hypertension the high blood pressure per se may be responsible for the renin suppression [3,4], this increase of renin activity is possibly the consequence of blood pressure reduction, while the decrease of renin activity after Visken may be the cause of blood pressure reduction.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
pindolol (Visken)对各种高血压患者血压和血浆肾素活性的影响。
1. 在20例边缘性高血压患者中,有20例(100%)使不稳定血压正常化。直立和尿潴留刺激后高肾素值明显降低(p < 0.01)。2. 在12例低肾素血症性原发性高血压患者中,3例(25%)单独使用Visken使血压恢复正常。低肾素值升高到正常范围。3.在18例正常肾素血症性高血压患者中的4例(22%)中,Visken使血压正常化。正常肾素值在正常范围内呈下降趋势。4. 在10例高肾素血症性高血压患者中有4例(40%),Visken使高血压正常化。其中3例肾素明显下降。5. 20例肾性高血压患者中有4例(20%)单独使用Visken治疗后血压恢复正常。3例高肾素值降至正常范围。6. 在II至V组的大多数其他患者中,利尿剂和利血平的额外治疗使血压正常化。在这些病例中,肾素值表现出不同的反应,对应于β阻断剂、利尿剂或利血平对血浆肾素活性的不同作用[7]。7. 有趣的是,Visken不仅抑制高肾素值(交界性高血压[6],高肾素血症性原发性高血压),还能使低肾素血症性原发性高血压患者的低肾素值升高至正常范围。因为在原发性高血压中,高血压本身可能是肾素抑制的原因[3,4],这种肾素活性的升高可能是血压降低的结果,而维斯肯后肾素活性的降低可能是血压降低的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Pharmacologic differentiation between various anti-arrhythmics in animal experiments]. [The effect of mexiletine in comparison to placebo on extrasystole at rest and under strain]. [Modern anti-arrhythmia agents with special regard to potassium metabolism]. [Clinical value of computer-assisted arrhythmia analysis]. [Treatment of ventricular extrasystole with mexiletine and Neo-gilurytmal in myocardial infarct patients].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1